Fingolimod for multiple sclerosis

N Engl J Med. 2012 Jan 26;366(4):339-47. doi: 10.1056/NEJMct1101691.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Algorithms
  • Central Nervous System / drug effects
  • Fingolimod Hydrochloride
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / physiopathology
  • Propylene Glycols / adverse effects
  • Propylene Glycols / pharmacology
  • Propylene Glycols / therapeutic use*
  • Sphingosine / adverse effects
  • Sphingosine / analogs & derivatives*
  • Sphingosine / pharmacology
  • Sphingosine / therapeutic use

Substances

  • Immunosuppressive Agents
  • Propylene Glycols
  • Fingolimod Hydrochloride
  • Sphingosine